Navidea Biopharmaceuticals, Inc. (NAVB) Social Stream
NAVIDEA BIOPHARMACEUTICALS INC (NAVB) Price Targets From Analysts
Use the tables below to see what analysts covering NAVIDEA BIOPHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-05-14 | 1 | $5 | $5 | $5 | $0.078 | 6310.26% |
2021-11-11 | 2 | $8 | $5 | $6.5 | $0.078 | 8233.33% |
Price Target Last Issued May 14, 2021
500 - Internal server error
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|
NAVB Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1 | 2 | 0 | 0 | 0 | 0 | 2 |
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NAVB as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, NAVIDEA BIOPHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 199.62% of them.
- NAVIDEA BIOPHARMACEUTICALS INC's number of analysts covering the stock is greater than 3.03% of all US stocks.
- In the context of Healthcare stocks, NAVIDEA BIOPHARMACEUTICALS INC's average analyst price target is higher than 17.29% of them.
- In terms of how NAVIDEA BIOPHARMACEUTICALS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 69.11% of that group.
In the Pharmaceutical Products industry, OCX, TRIB, and ABIO are the three stocks most similar to NAVIDEA BIOPHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is NAVB a Buy, Hold or Sell? See the POWR Ratings now!